Board Meeting Announcement for Nectar Lifescience Ltd - Jul 7, 2025

Nectar Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 inter alia to consider and approve the Audited Financial Results for the Financial Year 2024-25 Financial Statements of the Company for the Financial Year 2024-25 and matters related thereto. Please find attached herewith the reason for delay in financial results for the quarter and year ended on March 31, 2025. Please find attached herewith change in Directors as per letter. Further, please also be informed that the Audit Committee and Board of Directors could not approve and take on record the Audited Financial Results and Financial Statements for the quarter and year ended March 31, 2025. Therefore, the meetings stand adjourned sine die, for said matters. The reasons for delay in submission of financial results is being submitted by way of separate letter. The date of adjourned Board Meeting shall be intimated in due course of time. The trading window closure period is being extended accordingly till 48 hours after the declaration of Financial Results for the period ended on March 31, 2025 (As per BSE Announcement Dated on 30/05/2025) Nectar Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/07/2025 ,inter alia, to consider and approve the Audited Financial Results for the Financial Year 2024-25, Financial Statements of the Company for the Financial Year 2024-25 and matters related thereto (As Per BSE Announcement Dated on :03.07.2025)